- Home
- DAWN vs SEZL Comparison
DAWN vs SEZL Comparison
Compare DAWN & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- SEZL
- Stock Information
- Founded
- DAWN 2018
- SEZL 2016
- Country
- DAWN United States
- SEZL United States
- Employees
- DAWN N/A
- SEZL N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- SEZL Diversified Financial Services
- Sector
- DAWN Health Care
- SEZL Finance
- Exchange
- DAWN Nasdaq
- SEZL Nasdaq
- Market Cap
- DAWN 1.2B
- SEZL 1.3B
- IPO Year
- DAWN 2021
- SEZL N/A
- Fundamental
- Price
- DAWN $12.43
- SEZL $286.65
- Analyst Decision
- DAWN Strong Buy
- SEZL Strong Buy
- Analyst Count
- DAWN 7
- SEZL 2
- Target Price
- DAWN $36.17
- SEZL $366.00
- AVG Volume (30 Days)
- DAWN 782.5K
- SEZL 129.7K
- Earning Date
- DAWN 02-25-2025
- SEZL 02-25-2025
- Dividend Yield
- DAWN N/A
- SEZL N/A
- EPS Growth
- DAWN N/A
- SEZL 1005.78
- EPS
- DAWN N/A
- SEZL 9.51
- Revenue
- DAWN $101,953,000.00
- SEZL $221,806,305.00
- Revenue This Year
- DAWN N/A
- SEZL $59.52
- Revenue Next Year
- DAWN $35.37
- SEZL $33.19
- P/E Ratio
- DAWN N/A
- SEZL $30.16
- Revenue Growth
- DAWN N/A
- SEZL 49.13
- 52 Week Low
- DAWN $11.13
- SEZL $38.51
- 52 Week High
- DAWN $18.07
- SEZL $477.53
- Technical
- Relative Strength Index (RSI)
- DAWN 52.15
- SEZL 51.67
- Support Level
- DAWN $11.65
- SEZL $255.12
- Resistance Level
- DAWN $12.54
- SEZL $358.55
- Average True Range (ATR)
- DAWN 0.47
- SEZL 28.98
- MACD
- DAWN 0.02
- SEZL 6.09
- Stochastic Oscillator
- DAWN 80.53
- SEZL 49.91
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase.